Seroquel XR 300 mg tablete s produljenim oslobađanjem
Name | Seroquel XR 300 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-408184728 |
Active Substance | kvetiapinfumarat |
Composition | jedna tableta s produljenim oslobađanjem sadrži 300 mg kvetiapina (u obliku kvetiapinfumarata) |
Pharmaceutical Form | tableta s produljenim oslobađanjem |
Manufacturer | AstraZeneca UK Limited, Macclesfield, Cheshire, Ujedinjeno Kraljevstvo
AstraZeneca AB, Sodertalje, Švedska Cheplapharm Arzneimittel GmbH, Greifswald, Njemačka Klocke Pharma-Service GmbH, Appenweier, Njemačka |
Marketing Authorisation Holder | Cheplapharm Arzneimittel GmbH, Ziegelhof 24, Greifswald, Njemačka |
Marketing Authorisation Date | 02.11.2023 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/15-02/71 |
Registration Number | 381-12-01/70-23-62 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N05AH04 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2 |